---
title: "Chemfab Alkalis Ltd(Merged) (CHEMFALKAL) — Share Price, Financials & Analysis"
symbol: "CHEMFALKAL"
company: "Chemfab Alkalis Ltd(Merged)"
canonical: "https://tapetide.com/stocks/CHEMFALKAL"
nse_symbol: "CHEMFALKAL"
sector: "Commodities"
industry: "Chemicals & Petrochemicals"
generated_at: "2026-09-13T18:46:03.371Z"
---

# Chemfab Alkalis Ltd(Merged) (CHEMFALKAL)

Canonical page: https://tapetide.com/stocks/CHEMFALKAL

## Company

- **NSE Symbol:** CHEMFALKAL
- **Sector:** Commodities
- **Industry:** Chemicals & Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** DELISTED
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** chemfabalkalis.com

## About

Chemfab Alkalis (CAL) is an India-based company engaged in manufacturing inorganic chemicals. The Company offers chlor alkali and related products / services.

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- The company has delivered a poor sales growth of 4.84% over past five years.
- Company has a low return on equity of 9.62% over last 3 years.
- Dividend payout has been low at 10.5% of profits over last 3 years
- Debtor days have increased from 43.6 to 61.7 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -15% | -27% | 2% |
| revenue growth | -8% | -4% | 5% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 30.93 | 25.68 | 27.98 | 25.8 | 22.94 | 25.16 | 23.93 | 29.28 | 30.48 | 31.49 | 30.58 | 38.86 |
| Expenses | 24.16 | 21.03 | 22.21 | 21.23 | 18.63 | 17.58 | 17.99 | 23.19 | 19.37 | 22.17 | 22.62 | 30.15 |
| Operating Profit | 6.77 | 4.65 | 5.77 | 4.57 | 4.31 | 7.58 | 5.94 | 6.09 | 11.11 | 9.32 | 7.96 | 8.71 |
| OPM % | 21.89 | 18.11 | 20.62 | 17.71 | 18.79 | 30.13 | 24.82 | 20.8 | 36.45 | 29.6 | 26.03 | 22.41 |
| Other Income | 0.54 | 2.01 | 1.37 | 1.04 | 0.27 | -0.19 | -0.59 | 2.78 | 1.25 | 1.27 | 2.08 | 1.13 |
| Interest | 0.14 | 0.19 | 0.2 | 0.18 | 0.21 | 0.35 | 0.49 | 0.48 | 0.52 | 0.42 | 0.17 | 0.68 |
| Depreciation | 2.4 | 3.24 | 2.38 | 2.13 | 1.98 | 3.75 | 2.79 | 2.77 | 2.55 | 1.99 | 2 | 2.8 |
| Profit before tax | 4.77 | 3.23 | 4.56 | 3.3 | 2.39 | 3.29 | 2.07 | 5.62 | 9.29 | 8.18 | 7.87 | 6.36 |
| Tax % | 31.87 | 34.67 | 23.68 | 57.88 | 34.31 | 35.87 | 35.75 | 35.05 | 33.37 | 33.5 | 28.46 | 33.65 |
| Net Profit | 3.25 | 2.11 | 3.48 | 1.39 | 1.57 | 2.11 | 1.33 | 3.65 | 6.19 | 5.44 | 5.63 | 4.23 |
| EPS in Rs | 3.53 | 2.29 | 3.78 | 1.51 | 1.71 | 2.29 | 1.45 | 3.97 | 6.73 | 5.91 | 6.12 | 4.6 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 103 | 100 | 90 | 87 | 80 | 79 | 116 | 113 | 110 | 101 |
| Expenses | 71 | 74 | 70 | 74 | 65 | 61 | 78 | 86 | 88 | 78 |
| Operating Profit | 32 | 27 | 20 | 14 | 15 | 18 | 38 | 27 | 22 | 24 |
| OPM % | 31 | 27 | 22 | 16 | 19 | 22 | 33 | 24 | 20 | 23 |
| Other Income | 2 | 3 | 2 | 5 | 5 | 1 | 4 | 5 | 5 | 3 |
| Interest | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Depreciation | 6 | 7 | 9 | 8 | 8 | 7 | 7 | 6 | 10 | 11 |
| Profit before tax | 26 | 21 | 12 | 11 | 12 | 12 | 35 | 25 | 16 | 13 |
| Tax % | 33 | 34 | 34 | 32 | 21 | 37 | 33 | 34 | 36 | 35 |
| Net Profit | 18 | 14 | 8 | 7 | 10 | 7 | 23 | 16 | 10 | 9 |
| EPS in Rs | 19.2 | 15.27 | 8.52 | 7.84 | 10.51 | 8.12 | 25.52 | 17.88 | 11.12 | 9.41 |
| Dividend Payout % | 26 | 0 | 0 | 32 | 24 | 0 | 20 | 7 | 11 | 13 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 42 | 56 | 64 | 69 | 76 | 83 | 101 | 117 | 125 | 132 |
| Borrowings | 19 | 11 | 4 | 0 | 0 | 0 | 0 | 24 | 24 | 17 |
| Other Liabilities | 47 | 31 | 35 | 32 | 23 | 24 | 30 | 35 | 34 | 32 |
| Total Liabilities | 112 | 104 | 108 | 106 | 103 | 112 | 136 | 180 | 187 | 186 |
| Fixed Assets | 72 | 74 | 84 | 77 | 67 | 60 | 66 | 72 | 112 | 113 |
| CWIP | 1 | 4 | 1 | 1 | 1 | 2 | 2 | 60 | 21 | 14 |
| Investments | 0 | 2 | 1 | 7 | 22 | 24 | 26 | 7 | 11 | 0 |
| Other Assets | 39 | 24 | 22 | 21 | 13 | 27 | 41 | 42 | 44 | 60 |
| Total Assets | 112 | 104 | 108 | 106 | 103 | 112 | 136 | 180 | 187 | 186 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 24 | 23 | 15 | 18 | 11 | 6 | 31 | 16 | 20 | 16 |
| Cash from Investing Activity | -12 | -12 | -12 | -12 | -4 | 3 | -24 | -61 | -13 | -18 |
| Cash from Financing Activity | -13 | -9 | -8 | -5 | 5 | -3 | -5 | 24 | -2 | -9 |
| Net Cash Flow | -1 | 2 | -4 | 1 | 13 | 6 | 2 | -21 | 5 | -11 |
| Free Cash Flow | 12 | 11 | 3 | 10 | 7 | 6 | 15 | -46 | 7 | 6 |
| CFO/OP | 96 | 109 | 97 | 153 | 104 | 55 | 118 | 105 | 109 | 87 |

### Ratios

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 39 | 36 | 39 | 35 | 6 | 42 | 45 | 34 | 35 | 62 |
| Inventory Days | 317 | 176 | 153 | 139 | 129 | 160 | 182 | 176 | 165 | — |
| Days Payable | 161 | 71 | 70 | 123 | 56 | 221 | 747 | 798 | 650 | — |
| Cash Conversion Cycle | 194 | 141 | 122 | 51 | 79 | -18 | -520 | -588 | -450 | 62 |
| Working Capital Days | 17 | 15 | 10 | 10 | -3 | 30 | 1 | -5 | -9 | 19 |
| ROCE % | 47 | 32 | 18 | 14 | 13 | 15 | 35 | 20 | 11 | 10 |

## Shareholding Pattern

### annual

| Category | Mar 2017 |
| --- | --- |
| Promoters | 73.58% |
| FIIs | 0.51% |
| DIIs | 0.12% |
| Public | 25.79% |
| No. of Shareholders | 7016 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 |
| --- | --- | --- | --- | --- |
| Promoters | 73.58% | 73.58% | 73.58% | 73.58% |
| FIIs | 0% | 0% | 0% | 0.51% |
| DIIs | 0.1% | 0.1% | 0.12% | 0.12% |
| Public | 26.32% | 26.32% | 26.3% | 25.79% |
| No. of Shareholders | 5362 | 6329 | 7152 | 7016 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2.8 | Sell |
| EMA (10) | 2.76 | Sell |
| SMA (20) | 2.76 | Sell |
| EMA (20) | 2.74 | Sell |
| SMA (50) | 2.68 | Sell |
| EMA (50) | 2.74 | Sell |
| SMA (100) | 2.88 | Sell |
| EMA (100) | 2.86 | Sell |
| SMA (200) | 2.86 | Sell |
| EMA (200) | 3.27 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 48.31 | Neutral |
| MACD (12,26,9) | 0.03 | Sell |
| Stochastic (14,3,3) | 29.33 | Neutral |
| ADX (14) | 18.96 | Neutral |
| Williams %R (14) | -70.87 | Neutral |
| ATR (14) | 0.3 | High Volatility |
| ROC (12) | 1.52 | Buy |
| Stoch RSI (14) | 5.91 | Buy |
| UO (7,14,28) | 48.8 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Postal ballot passed: office shift to Pune; Dharwad land sale approved; Chirag C. Doshi re-appointed MD from April 1, 2026. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 9h - Postal ballot passed: office shift to Pune; Dharwad land sale approved; Chirag C. Doshi re-appointed MD from April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/61ddfbea-b83f-446a-8dd5-a0e1ee6c95df.pdf) |
| 5 Feb - Postal ballot to shift registered office to Pune, sell Dharwad land, reappoint MD Chirag Doshi April 1, 2026. | [Postal Ballot - General Updates 5 Feb - Postal ballot to shift registered office to Pune, sell Dharwad land, reappoint MD Chirag Doshi April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/020b8b8a-0d4c-4ad9-b85e-7bbdbbc60858.pdf) |
| 30 Jan - Chirag C. Doshi re-appointed MD & CEO for three years from April 1, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 30 Jan - Chirag C. Doshi re-appointed MD & CEO for three years from April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8f295a88-6a05-4537-855b-e1735355f672.pdf) |
| 30 Jan - Board approved shifting registered office from Mumbai to Pune (Siddharth Towers), subject to members' approval, Jan 29, 2026. | [Announcement under Regulation 30 (LODR)-Change in Registered Office Address 30 Jan - Board approved shifting registered office from Mumbai to Pune (Siddharth Towers), subject to members' approval, Jan 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d74b4217-7192-4bb1-b879-a3d2adcf821c.pdf) |
| 11h - Settled arbitration with Aicitta; recovering Rs.2,12,41,096 in instalments; last payment by Aug 08, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015. 11h - Settled arbitration with Aicitta; recovering Rs.2,12,41,096 in instalments; last payment by Aug 08, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/28b0c0db-34da-40bc-a81a-932d253f0c29.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cfe3d788-7f10-4017-a78c-03cebb2116e8.pdf) |
| — | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 5 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/283a83ff-23f6-40f4-b0f8-ed08a1380b8c.pdf) |
| — | [Statement Of Un-Audited Special Purpose Financial Results For The Quarter Ended 30.06.2017 27 Jul 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd5861d-cd13-47c7-a4b1-64ef4f771f85.pdf) |
| — | [Statement Of Un-Audited Special Purpose Financial Results For The Quarter Ended 30.06.2017 27 Jul 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/7/cbd5861d-cd13-47c7-a4b1-64ef4f771f85.pdf) |
| — | [Board Meeting On July 27 2017 25 Jul 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92c974c9-9e87-44f7-9773-8355e381ecb3.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3cd97efb-af57-4969-8119-71ff69aba005.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/95540814-38d3-46f5-b7b9-7185f0d12b9f.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/379583fd-acfe-4e92-b069-58e8b5505b30.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/df315c1b-0a80-498d-83f1-37c83f61f6bf.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2640d907-f72c-4def-89ed-87458b612ee8.pdf) |
| Feb 2019 | [Concall - Feb 2019](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2019/2/8e801385-cb48-4da1-84c7-6cae088ca523.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3088_WALCHANNAG_2012_2013_01012014094522.zip) |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_CHEMFALKAL_2011_2012_22062012111417.zip) |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_WALCHANNAG_2011_2012_08012013102230.zip) |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_CHEMFALKAL_2009_2010_18082010121500.zip) |
| from nse | [Annual Report 2009 from nse](https://archives.nseindia.com/annual_reports/AR_CHEMFALKAL_2008_2009_08102009102500.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20ff67b9-9668-4ef0-ae04-3aae19b8bf0b.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04c57804-6e56-4d2b-b3ed-8dd97c1aa3c5.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0968e6b-eb3f-4c49-8297-3004cc9ff83e.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/507410/77282507410.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/507410/69064507410.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:46:03.371Z.